Related Experiment Videos
Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice
1Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
The Journal of Pharmacology and Experimental Therapeutics
|April 17, 2001
Summary
Cannabinoid CB(1) receptor agonists cause motor incoordination and ataxia in mice by affecting cerebellar function. These effects are CB(1) receptor-mediated and not influenced by dopamine pathways.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- The endocannabinoid system, including the CB(1) receptor, plays a crucial role in regulating motor control.
- Cannabinoid agonists are known to produce various behavioral effects, but their specific impact on cerebellar function requires detailed characterization.
Purpose of the Study:
- To investigate the effects of CB(1) receptor agonists on cerebellar function in mice.
- To determine if these effects are mediated by the CB(1) receptor and not by dopaminergic pathways.
Main Methods:
- Utilized gait analysis and the bar cross test to assess cerebellar function in mice.
- Administered various CB(1) receptor agonists (e.g., CP55940, THC, AEA) and an antagonist (SR141716).
- Tested the influence of dopamine receptor agonists (apomorphine, bromocriptine) on cannabinoid-induced effects.
Main Results:
- CB(1) receptor agonists significantly increased gait width (truncal ataxia) and slips on the bar cross test (motor incoordination).
- The CB(1) receptor antagonist SR141716 reversed these behavioral deficits.
- Dopamine receptor agonists did not attenuate the observed motor impairments, indicating a non-dopaminergic mechanism.
Conclusions:
- CB(1) receptor activation in mice leads to cerebellar dysfunction, manifesting as ataxia and motor incoordination.
- These findings confirm the specific role of the CB(1) receptor in mediating these behavioral deficits.
- The study provides evidence that cannabinoid-induced motor impairments are primarily mediated through cerebellar pathways, independent of nigrostriatal dopaminergic transmission.